These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12789401)

  • 1. The economic divide and tuberculosis. Tuberculosis is not just a medical problem, but also a problem of social inequality and poverty.
    van Helden PD
    EMBO Rep; 2003 Jun; 4 Spec No(Suppl 1):S24-8. PubMed ID: 12789401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost for tuberculosis care in developed countries: which data for an economic evaluation?
    Trieste L; Turchetti G
    J Rheumatol Suppl; 2014 May; 91():83-5. PubMed ID: 24789005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis: where are we going?
    Davies PD
    Clin Med (Lond); 2007; 7(1):90. PubMed ID: 17348587
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.
    Hotez PJ; Molyneux DH; Fenwick A; Ottesen E; Ehrlich Sachs S; Sachs JD
    PLoS Med; 2006 Jan; 3(5):e102. PubMed ID: 16435908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings.
    Bastos ML; Campbell JR; Oxlade O; Adjobimey M; Trajman A; Ruslami R; Kim HJ; Baah JO; Toelle BG; Long R; Hoeppner V; Elwood K; Al-Jahdali H; Apriani L; Benedetti A; Schwartzman K; Menzies D
    Ann Intern Med; 2020 Aug; 173(3):169-178. PubMed ID: 32539440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis and poverty].
    Emmanuelli X; Grosset J
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):169-71. PubMed ID: 12844011
    [No Abstract]   [Full Text] [Related]  

  • 7. Would pan-tuberculosis treatment regimens be cost-effective?
    Kendall EA; Brigden G; Lienhardt C; Dowdy DW
    Lancet Respir Med; 2018 Jul; 6(7):486-488. PubMed ID: 29859919
    [No Abstract]   [Full Text] [Related]  

  • 8. Parameters that influence the prediction of epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosis.
    Vani J; Maddur MS; Lacroix-Desmazes S; Kaveri SV; Bayry J
    Proc Natl Acad Sci U S A; 2009 Nov; 106(46):E129; author reply E130. PubMed ID: 19858487
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tuberculosis--social, economic and political problem. Two billions of people are infected].
    Thorson A; Lönnroth K; Diwan V
    Lakartidningen; 2004 Jan; 101(5):390-4. PubMed ID: 14986449
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of latent tuberculosis infection in immigrants.
    Menzies D; Schwartzman K
    N Engl J Med; 2003 Mar; 348(13):1289-92; author reply 1289-92. PubMed ID: 12661572
    [No Abstract]   [Full Text] [Related]  

  • 11. Private players in tuberculosis control: will negotiation help to maintain the symbiosis in the ecosystem?
    Atre S
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1524. PubMed ID: 25517824
    [No Abstract]   [Full Text] [Related]  

  • 12. TB drug prices slashed for poor countries.
    Hagmann M
    Bull World Health Organ; 2001; 79(9):904-5. PubMed ID: 11584747
    [No Abstract]   [Full Text] [Related]  

  • 13. Only a fraction of TB patients get the best care.
    J Adv Nurs; 2002 Aug; 39(3):215-6. PubMed ID: 12174835
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis treatment programmes in low-income countries.
    Nunn P; Weil D; Kumaresan J
    Lancet; 1994 Jun; 343(8913):1640. PubMed ID: 7980766
    [No Abstract]   [Full Text] [Related]  

  • 15. $ 1.4 billion funding shortfall for tuberculosis control.
    Burki T
    Lancet Infect Dis; 2013 Dec; 13(12):1016-7. PubMed ID: 24400359
    [No Abstract]   [Full Text] [Related]  

  • 16. A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis.
    Burman WJ; Dalton CB; Cohn DL; Butler JR; Reves RR
    Chest; 1997 Jul; 112(1):63-70. PubMed ID: 9228359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCIO-ECONOMIC CONSTRAINS FACED BY TB PATIENTS THAT LEAD TO NON-COMPLIANCE - A CROSS SECTIONAL STUDY IN SOUTHERN PUNJAB, PAKISTAN.
    Khan AA; Akhtar N; Madni A; Tahir N; Rehman M; Raza A; Qadir A
    Acta Pol Pharm; 2017 May; 74(3):995-1000. PubMed ID: 29513970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of questionnaires of patients having refused to undergo antituberculous therapy].
    Valetskyĭ IuM
    Lik Sprava; 2002; (5-6):39-41. PubMed ID: 12442517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to TB treatment in Ethiopia: why do patients default?
    Tesfaye H
    PLoS Med; 2007 Apr; 4(4):e165. PubMed ID: 17456000
    [No Abstract]   [Full Text] [Related]  

  • 20. Tuberculosis, a neglected opportunity?
    Harper C
    Nat Med; 2007 Mar; 13(3):309-12. PubMed ID: 17342146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.